132 related articles for article (PubMed ID: 4762582)
1. Quantitative assessment of fibrinolysis on isolated glomeruli.
Sraer JD; Boelaert J; Mimoune O; Morel-Maroger L; Hornych H
Kidney Int; 1973 Nov; 4(5):350-2. PubMed ID: 4762582
[No Abstract] [Full Text] [Related]
2. Tranexamic acid and fibrinolytic activity of the vessel wall.
Astedt B; Liedholm P
Experientia; 1974 Jul; 30(7):776-7. PubMed ID: 4847668
[No Abstract] [Full Text] [Related]
3. Synthetic inhibitors of fibrinolysis: in vitro and in vivo mode of action.
Okamoto S; Oshiba S; Mihara H; Okamoto U
Ann N Y Acad Sci; 1968 Jun; 146(2):414-29. PubMed ID: 5254270
[No Abstract] [Full Text] [Related]
4. Biphasic inhibition of urokinase-induced fibrinolysis by epsilon-aminocaproic acid; distinction from tissue plasminogen activator.
Thorsen S; Astrup T
Proc Soc Exp Biol Med; 1969 Mar; 130(3):811-3. PubMed ID: 5773672
[No Abstract] [Full Text] [Related]
5. Influence of fibrinolysis and coagulation on haemostatic plug formation. An experimental study in rabbits.
Bergqvist D; Arfors KE
Thromb Res; 1974 Feb; 4(2):345-60. PubMed ID: 4831008
[No Abstract] [Full Text] [Related]
6. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
Landmann H
Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
[No Abstract] [Full Text] [Related]
7. Effects of tranexamic acid, cis-AMCHA, and 6-aminohexanoic acid on the activation rate of plasminogen by urokinase in the presence of clot.
Takada A; Ohashi H; Matsuda H; Takada Y
Thromb Res; 1979; 14(6):915-23. PubMed ID: 473126
[No Abstract] [Full Text] [Related]
8. Metabolism and distribution of fibrinogen. I. Fibrinogen turnover in physiological conditions in humans.
Collen D; Tytgat GN; Claeys H; Piessens R
Br J Haematol; 1972 Jun; 22(6):681-700. PubMed ID: 5064500
[No Abstract] [Full Text] [Related]
9. Some properties of the tissue plasminogen activator from the pig heart.
Hijikata A; Fujimoto K; Kitaguchi H; Okamoto S
Thromb Res; 1974 Jun; 4(6):731-40. PubMed ID: 4844057
[No Abstract] [Full Text] [Related]
10. Influence of antifibrinolytic substances on allergic reactions. Experiments with epsilon-aminocaproic acid and amino-methyl-cyclohexane-carbonic acid.
Raab W
Experientia; 1968 Mar; 24(3):250. PubMed ID: 5661420
[No Abstract] [Full Text] [Related]
11. Medicinal chemical studies on antiplasmin drugs. 4. Chemical modification of trans-4-aminomethylcyclohexanecarboxylic acid and its effect on antiplasmin activity.
Okano A; Inaoka M; Funabashi S; Iwamoto M; Isoda S
J Med Chem; 1972 Mar; 15(3):247-55. PubMed ID: 5059209
[No Abstract] [Full Text] [Related]
12. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates.
Skoza L; Tse AO; Semar M; Johnson AJ
Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440
[No Abstract] [Full Text] [Related]
13. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
Markwardt F; Klöcking HP
Biomed Biochim Acta; 1983; 42(6):725-30. PubMed ID: 6605748
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen-plasmin system. 3. Kinetics of plasminogen activation and inhibition of plasminogen-plasmin system by some synthetic inhibitors.
Iwamoto M; Abiko Y; Shimizu M
J Biochem; 1968 Dec; 64(6):759-67. PubMed ID: 4238017
[No Abstract] [Full Text] [Related]
15. Fibrinogen turnover and drugs acting on fibrinolysis.
De Nicola P
Acta Univ Carol Med Monogr; 1972; 52():25-31. PubMed ID: 4544612
[No Abstract] [Full Text] [Related]
16. Pulmonary tissue fibrinolysis in traumatized rats pretreated with tranexamic acid.
Risberg B; Peterson HI
Microvasc Res; 1977 Jan; 13(1):91-5. PubMed ID: 859454
[No Abstract] [Full Text] [Related]
17. A light and electron microscopic study of arteries and other tissues from dogs subjected to chronic fibrinolytic inhibition with AMCHA.
Steenblock DA; Celander DR
Vasc Surg; 1968 Sep; 2(3):149-56. PubMed ID: 5759058
[No Abstract] [Full Text] [Related]
18. Studies on the mechanism of action of inhibitors of the fibrinolysin system.
Ambrus CM; Ambrus JL; Lassman HB; Mink IB
Ann N Y Acad Sci; 1968 Jun; 146(2):430-47. PubMed ID: 4239437
[No Abstract] [Full Text] [Related]
19. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA.
Andersson L; Nilsoon IM; Colleen S; Granstrand B; Melander B
Ann N Y Acad Sci; 1968 Jun; 146(2):642-58. PubMed ID: 5254275
[No Abstract] [Full Text] [Related]
20. Plasminogen-plasmin system. VII. Potentiation of antifibrinolytic action of a synthetic inhibitor, tranexamic acid, by alpha 2-macroglobulin antiplasmin.
Abiko Y; Iwamoto M
Biochim Biophys Acta; 1970 Sep; 214(3):411-8. PubMed ID: 4251764
[No Abstract] [Full Text] [Related]
[Next] [New Search]
